Biogen

TOFIDENCE

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Biogen

TOFIDENCE HCPCS:

Q5133

HCPCS Code Descriptor:

Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg

Category:

Q Code

TOFIDENCE NDCs:

Primary Type:

Immunosuppressant

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Tofidence CPT Codes:

Potential CPT administration codes for Tofidence can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About TOFIDENCE:

TOFIDENCE is manufactured by Biogenand aligned to the Q Code: Q5133. TOFIDENCE is a Immunosuppressant medication administered via the Intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

Q5133 Added Date:

April 1, 2024

Q5133 Effective Date:

April 1, 2024

Q5133 Termination Date:

HCPCS Active

We have not identified a manufacturer-published billing and coding guide for TOFIDENCE
Our team has not identified a source of patient assistance information for TOFIDENCE
TOFIDENCE prescribing information can be found at the link below:
Our team has not yet identified a source of side effect information for TOFIDENCE.